These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


115 related items for PubMed ID: 9283908

  • 41. Biological and clinical relevance of matrix metalloproteinases 2 and 9 in acute myeloid leukaemias and myelodysplastic syndromes.
    Travaglino E, Benatti C, Malcovati L, Della Porta MG, Gallì A, Bonetti E, Rosti V, Cazzola M, Invernizzi R.
    Eur J Haematol; 2008 Mar; 80(3):216-26. PubMed ID: 18081721
    [Abstract] [Full Text] [Related]

  • 42. Regulation of angiogenesis in the bone marrow of myelodysplastic syndromes transforming to overt leukaemia.
    Keith T, Araki Y, Ohyagi M, Hasegawa M, Yamamoto K, Kurata M, Nakagawa Y, Suzuki K, Kitagawa M.
    Br J Haematol; 2007 May; 137(3):206-15. PubMed ID: 17408459
    [Abstract] [Full Text] [Related]

  • 43. Therapy-related myelodysplastic syndrome with monosomy 5 after successful treatment of acute myeloid leukemia (M2).
    Ogasawara T, Yasuyama M, Kawauchi K.
    Am J Hematol; 2005 Jun; 79(2):136-41. PubMed ID: 15929101
    [Abstract] [Full Text] [Related]

  • 44. [Retrospective study of acute myelogenous leukemia in 83 elderly patients: clinical and biological characteristics].
    Tsuzuki M, Ino T, Hasegawa A, Miyazaki H, Kojima H, Maruyama F, Okamoto M, Matsui T, Ezaki K, Hirano M.
    Rinsho Ketsueki; 2000 Apr; 41(4):296-302. PubMed ID: 10846459
    [Abstract] [Full Text] [Related]

  • 45. Outcome assessment of age group-specific (+/- 50 years) post-remission consolidation with high-dose cytarabine or bone marrow autograft for adult acute myelogenous leukemia.
    Bassan R, Raimondi R, Lerede T, D'emilio A, Buelli M, Borleri G, Personeni A, Bellavita P, Rodeghiero F, Barbui T.
    Haematologica; 1998 Jul; 83(7):627-35. PubMed ID: 9718868
    [Abstract] [Full Text] [Related]

  • 46. Prognostic significance of dysplastic features of hematopoiesis in patients with de novo acute myelogenous leukemia.
    Kahl C, Florschütz A, Müller G, Jentsch-Ullrich K, Arland M, Leuner S, Franke A, Höffkes HG.
    Ann Hematol; 1997 Sep; 75(3):91-4. PubMed ID: 9368477
    [Abstract] [Full Text] [Related]

  • 47. Clonal evolutions during long-term cultures of bone marrow from de novo acute myeloid leukaemia with trilineage myelodysplasia and with myelodysplastic remission marrow.
    Tamura S, Kanamaru A, Takemoto Y, Kakishita E, Nagai K.
    Br J Haematol; 1993 Jun; 84(2):219-26. PubMed ID: 8398821
    [Abstract] [Full Text] [Related]

  • 48. [Clonogenic cells of acute leukemia secondary to myeloproliferative and myelodysplastic syndromes].
    Almeida J, del Cañizo MC, Galende J, Vidriales B, Nieto MJ, Hernández MD, Rodríguez MJ, San Miguel JF.
    Sangre (Barc); 1994 Oct; 39(5):331-5. PubMed ID: 7754436
    [Abstract] [Full Text] [Related]

  • 49. Clonal remissions in acute myeloid leukaemia are commonly associated with features of trilineage myelodysplasia during remission.
    Jowitt SN, Liu Yin JA, Saunders MJ, Lucas GS.
    Br J Haematol; 1993 Dec; 85(4):698-705. PubMed ID: 7918032
    [Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. Correlative patterns of neutrophil and platelet counts during very early remission of acute myeloblastic leukemia.
    Ventura GJ, Drewinko B, Keating MJ.
    Hematol Pathol; 1987 Dec; 1(2):113-6. PubMed ID: 3504433
    [Abstract] [Full Text] [Related]

  • 52. Therapy-related myeloid neoplasms following treatment for multiple myeloma-a single center analysis.
    Boquoi A, Banahan SM, Mohring A, Savickaite I, Strapatsas J, Hildebrandt B, Kobbe G, Gattermann N, Haas R, Schroeder T, Germing U, Fenk R.
    Ann Hematol; 2022 May; 101(5):1031-1038. PubMed ID: 35262868
    [Abstract] [Full Text] [Related]

  • 53. Disappearing myelodysplastic syndrome-associated hemolytic anemia in leukemic transformation.
    Tabata R, Tabata C, Omori K, Nagai T.
    Int Arch Allergy Immunol; 2010 May; 152(4):407-12. PubMed ID: 20197683
    [Abstract] [Full Text] [Related]

  • 54. Dysplastic macropolycytes in myelodysplasia-related acute myeloid leukemia.
    Bain BJ.
    Am J Hematol; 2011 Sep; 86(9):776. PubMed ID: 21509797
    [No Abstract] [Full Text] [Related]

  • 55. Infection and hemorrhage in elderly acute myeloblastic leukemia and primary myelodysplasia.
    Barbui T, Cortelazzo S, Viero P, Buelli M, Bassan R.
    Hematol Oncol; 1993 Sep; 11 Suppl 1():15-8. PubMed ID: 7683621
    [No Abstract] [Full Text] [Related]

  • 56. Remission with morphological myelodysplasia in de novo acute myeloid leukaemia: implications for early relapse.
    Nagai K, Matsuo T, Atogami S, Moriuchi Y, Yoshida Y, Kuriyama K, Tomonaga M.
    Br J Haematol; 1992 May; 81(1):33-9. PubMed ID: 1520622
    [Abstract] [Full Text] [Related]

  • 57. Granulocyte, monocyte and blast immunophenotype abnormalities in acute myeloid leukemia with myelodysplasia-related changes.
    Ayar SP, Ravula S, Polski JM.
    Ann Clin Lab Sci; 2014 May; 44(1):3-9. PubMed ID: 24695467
    [Abstract] [Full Text] [Related]

  • 58. De novo AML with trilineage myelodysplasia and a novel t(11;12)(p15;q13).
    Wong KF, Kwong YL, So CC.
    Cancer Genet Cytogenet; 1998 Jan 01; 100(1):49-51. PubMed ID: 9406580
    [Abstract] [Full Text] [Related]

  • 59. Peripheral blood features of acute myeloid leukemia with myelodysplasia-related changes developing in a patient with sickle cell anemia.
    Zemenides S, Erblich T, Luqmani A, Bain BJ.
    Am J Hematol; 2014 Oct 01; 89(10):1010. PubMed ID: 24852219
    [No Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 6.